2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal SubtypeAdvanced Breast Cancer; Advanced Breast Carcinoma; Hormone Receptor Positive Breast CarcinomaRecruitingPhase 22026-07-30NCT06486883
Study on Safety and Performance of AdvanCore Bone Void FillerBone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, bone fracture, injury, metabolic disease, musculoskeletal system disorderRecruitingNot applicable2025-05-31NCT06736457